Vafseo® (vadadustat) – New drug approval
March 27, 2024 - Akebia announced the FDA approval of Vafseo (vadadustat), for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least three months.
Download PDF
